Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$11.74−1.01 (-7.92%)
Close on Nov 17, 2026Market cap $79.70MP/E –Yield –
Eloxx Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Eloxx Pharmaceuticals's cash was $61.96M at Jun 30, 2026. For fiscal 2025 it was $4.79M, up 4210.8% from the year before. Over ten years it grew -2.4% a year on average. The highest annual figure on record is $56.28M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.79M | +4210.8% |
| FY2024 | Dec 31, 2024 | $111.00K | -90.2% |
| FY2023 | Dec 31, 2023 | $1.13M | -94.1% |
| FY2022 | Dec 31, 2022 | $19.21M | -54.6% |
| FY2021 | Dec 31, 2021 | $42.27M | +71.3% |
| FY2020 | Dec 31, 2020 | $24.67M | -56.2% |
| FY2019 | Dec 31, 2019 | $56.28M | +15.8% |
| FY2018 | Dec 31, 2018 | $48.61M | +5894.8% |
| FY2016 | Jun 30, 2016 | $810.81K | -75.7% |
| FY2015 | Jun 30, 2015 | $3.33M | -45.4% |
| FY2014 | Jun 30, 2014 | $6.11M | +281.4% |
| FY2013 | Jun 30, 2013 | $1.60M | -19.9% |
| FY2012 | Jun 30, 2012 | $2.00M | -44.6% |
| FY2011 | Jun 30, 2011 | $3.61M | -55.0% |
| FY2010 | Jun 30, 2010 | $8.03M | +2009.0% |
| FY2009 | Jun 30, 2009 | $380.57K | – |
| FY1998 | Jun 30, 1998 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $61.96M | +13668.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $6.36M | +5632.4% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $4.79M | +322.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $572.00K | -88.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $450.00K | -89.6% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $111.00K | -97.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.13M | -94.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $4.78M | -80.6% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $4.33M | -85.6% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $4.90M | -87.7% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $19.21M | -54.6% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $24.55M | -53.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $30.05M | -47.0% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $39.77M | +117.9% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $42.27M | +71.3% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $52.43M | +71.4% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $56.73M | +52.9% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $18.25M | -58.5% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $24.67M | -56.2% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $30.59M | -52.9% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $37.12M | -51.4% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $43.96M | -17.8% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $56.28M | +15.8% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $64.94M | +17.3% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $76.30M | +20.3% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $53.50M | +192.5% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $48.61M | +5894.8% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $55.34M | +3527.2% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $63.41M | +4528.6% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $18.29M | +445.2% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $810.81K | -75.7% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $1.53M | +224.6% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $1.37M | -21.1% |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $3.35M | -12.6% |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $3.33M | -45.4% |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $469.98K | -92.4% |
| Q2 FY2015CQ4 2014 | Dec 31, 2014 | $1.74M | – |
| Q1 FY2015CQ3 2014 | Sep 30, 2014 | $3.84M | – |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | $6.11M | – |
| Q3 FY2014CQ1 2014 | Mar 31, 2014 | $6.20M | – |
See a number that looks wrong?